HQH 最近表现不佳，应是与资本利得大幅下滑导致配息中有 1/3 来自本金有关，
想请教 HQH 的投资组合或是整个生技市场是否有大变化? 未来前景如何? 谢谢!
附上这次的配息结构 https://goo.gl/8t8UuX
HQH Mar/29/2018
Net Investment Income $0.0000 0%
Net Realized ST Cap Gains $0.0914 19%
Net Realized LT Cap Gains $0.2276 47%
Return of Capital/Other Capital Source $0.1610 34%
TOTAL (per common share): $0.4800